In a recent retrospective study by Kramer et al. the beneficial effects of PDE5 inhibitors on 6-min walk test distance, HF functional class, NT-proBNP levels, RV function, and hospitalization rates were demonstrated in 40 patients with HFpEF and Cpc-PH and precisely characterized hemodynamics [125]. This evidence concerns the gene PDE5A and hydrops fetalis.